Navigation Links
Efficacy Advantages and Long-Term Cost Savings Will Help Optimize Reimbursement in the EU5 for Type 2 Diabetes Agents
Date:8/26/2013

BURLINGTON, Mass., Aug. 26, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that as the health technology assessment bar rises sharply across the EU5 (France, Germany, Italy, Spain and the United Kingdom), interviewed payers seek robust efficacy advantages over the right comparators and clear demonstration of potential for downstream cost savings in exchange for optimal reimbursement of type 2 diabetes therapies. As type 2 diabetes becomes increasingly prevalent in Western markets, the cost of related complications and comorbidities weighs heavily on tightening EU5 healthcare budgets. Payers report that novel agents that delay disease progression and show positive weight loss and cardiovascular outcomes data, ideally with detailed pharmacoeconomic analyses, will secure favorable market access conditions long term.

(Logo: http://photos.prnewswire.com/prnh/20130103/MM36784LOGO )

The new European Physician and Payer Forum report entitled Market Access Challenges Facing Newly Launched and Emerging Type 2 Diabetes Agents in the EU5: Physician Prescribing Perspectives and Payer Insights finds that at least three-quarters of surveyed EU5 endocrinologists, diabetologists and general practitioners (GPs) believe that, despite market crowding, unmet need remains for the DPP-IV inhibitor drug class, while at least two-thirds think likewise for the GLP-1 receptor agonists. Key unmet needs highlighted for the DPP-IV inhibitors include better reduction in HbA1c, and confirmation of disease-modifying effect, while—in addition to injection-free admin
'/>"/>

SOURCE Decision Resources
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Renal Dialysis Equipment Market to 2017- Lower Costs and Similar Efficacy Rates as Hemodialysis to Increase Adoption Rates of Peritoneal Dialysis
2. MedQIA unique CAD algorithm for Quantitation of lung involvement in diffuse lung disease used as treatment efficacy end point in study to be reported at the ERS Annual Conference in Vienna, Austria: September 1-5, 2012
3. Lilly Stops Phase III Development of Pomaglumetad Methionil For the Treatment of Schizophrenia Based on Efficacy Results
4. Sosei Group Corporation: Data at ERS Shows Efficacy of Once-daily COPD Portfolio Versus Comparators, Further Establishes Dual-bronchodilator QVA149
5. Optimization of Comparative Efficacy Trials
6. JAMA Study Demonstrates Efficacy of Life Technologies Lung Cancer Test in Detecting Early Metastases, Supports Screening for Lung Cancer
7. Efficacy and Safety Data from Phase 2B Trials of Janssens Simeprevir in Hepatitis C Patients with Advanced Fibrosis of the Liver Presented at Annual Meeting of the American Association for the Study of Liver Diseases
8. OncoSec Medical Reports Positive Interim Efficacy Results from Phase IV Study of NeoPulse in Skin Cancer Patients
9. OncoSec Medical Reports Positive Preliminary Efficacy Results from Phase II Study of ImmunoPulse in Metastatic Melanoma Patients
10. Lilly Discontinues Phase 3 Rheumatoid Arthritis Program for Tabalumab Based on Efficacy Results
11. Data Demonstrating the Safety and Efficacy of Chimerixs Antiviral CMX001 Presented at BMT Tandem Meetings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... SAN DIEGO , May 26, 2015 /PRNewswire/ ... in developing targeted therapeutic devices to address infectious ... A. Joyce , Chief Executive Officer, will present ... on Thursday, May 28th.  Details of Aethlon Medical,s ... Microcap Investor Conference Date: , Thursday, May 28, ...
(Date:5/26/2015)... , May 26, 2015  Array BioPharma Inc. ... Chief Executive Officer, Ron Squarer , will ... in New York City. The public is welcome to ... the Array BioPharma website.Event: Jefferies 2015 Global Healthcare ... p.m. Eastern Time Webcast: www.arraybiopharma.com  About Array BioPharma ...
(Date:5/26/2015)... 26, 2015  LabStyle Innovations Corp. (DRIO), ... announced today that in partnership with ... Healthcare, it has launched  the comprehensive Dario™ ... advanced Telecare unit (MOMA). The Dario™ is ... enables remote treatment for diabetes aiming to ...
Breaking Medicine Technology:Aethlon Medical to Present at SeeThruEquity Microcap Investor Conference 2Aethlon Medical to Present at SeeThruEquity Microcap Investor Conference 3Aethlon Medical to Present at SeeThruEquity Microcap Investor Conference 4LabStyle Innovations and Maccabi Healthcare Launch Dario Platform for Remote Treatment of Diabetes in Israel 2LabStyle Innovations and Maccabi Healthcare Launch Dario Platform for Remote Treatment of Diabetes in Israel 3LabStyle Innovations and Maccabi Healthcare Launch Dario Platform for Remote Treatment of Diabetes in Israel 4
... Carrot Medical, a leading manufacturer of integrated medical imaging display ... the year, Carrot Medical achieved significant growth in sales and ... half of 2011 with record second quarter sales, Carrot surpassed ...  The company is now well positioned for the third straight ...
... comedienne and TV favourite Jo Brand has joined forces with ... brand new comedy film (54 seconds) to launch Macmillan Cancer ... Jo Brand running around South London, in what looks like ... with Joanna Scanlan and produces a pint of milk; it ...
Cached Medicine Technology:Carrot Medical Positioned for Third Straight Year of Triple Digit Growth 2TV Favourite Jo Brand Puts Her Best Foot Forward for Macmillan Cancer Support 2TV Favourite Jo Brand Puts Her Best Foot Forward for Macmillan Cancer Support 3
(Date:5/26/2015)... 26, 2015 Over 700 doctors, nutritionists, ... to the secretaries of the U.S. Department of ... Services urging them to embrace the 2015 Dietary Guidelines ... plants for human health, economic prosperity, and our nation’s ... signed the letter, including: Dr. David Katz, founding director ...
(Date:5/26/2015)... 26, 2015 The American Association of ... 55 poison centers applaud the efforts of the United ... according to Stephen T. Kaminski, JD, AAPCC CEO and ... Substances Act, introduced by Senator Edward J. Markey on ... opioid pain medications and other controlled substances to undergo ...
(Date:5/26/2015)... Grove Village, IL (PRWEB) May 26, 2015 ... getting ready for the summer season, and thanks ... in hearing wellness solutions, more of their musicians ... earplugs. , With over 400 participating groups, ... Vic Firth Earplugs by Etymotic are now for ...
(Date:5/26/2015)... (PRWEB) May 26, 2015 Octo Consulting ... and management consulting solutions to the federal marketplace, has ... and Cloud Solutions. In this newly created role, Pal ... and growth in cloud computing, big data, and digital ... expanding leadership team as we continue to bring clients ...
(Date:5/26/2015)... Relias Learning , the leader ... and human services market, announces expansion of their user ... attendance and participation in 2014, they will double the ... user conference an exciting new facelift. , Regional ... and discuss best practices, share their expertise, provide feedback ...
Breaking Medicine News(10 mins):Health News:700 Doctors, Health Professionals, Including the American College of Lifestyle Medicine, Support Dietary Guidelines Message to Eat Less Meat, More Plants 2Health News:700 Doctors, Health Professionals, Including the American College of Lifestyle Medicine, Support Dietary Guidelines Message to Eat Less Meat, More Plants 3Health News:American Association of Poison Control Centers Supports Legislative Initiatives Targeting the Responsible Prescription of Opioid Pain Medication 2Health News:American Association of Poison Control Centers Supports Legislative Initiatives Targeting the Responsible Prescription of Opioid Pain Medication 3Health News:Marching Musicians Getting In Step With Hearing Protection 2Health News:Octo Consulting Group (Octo) Appoints Gaurav “GP” Pal as Vice President of Technology Strategy and Cloud Solutions 2Health News:Relias Learning Expands User Groups and Industry Influence 2Health News:Relias Learning Expands User Groups and Industry Influence 3
... News) -- The first artificial heart valve that can ... the U.S. Food and Drug Administration. The Sapien ... heart valve damaged by senile aortic valve stenosis, a ... cause the valve to narrow. One expert called ...
... inserted in the cerebral cortex of a rat model turns nearly ... less of the tough scarring that walls off hard probes that ... In the first test of the nanocomposite probe inspired by ... compared to that of a metal probe, and appeared to enable ...
... time, researchers have combined gene therapy and stem ... bleeding disorder hemophilia A in large animals, opening ... for human patients. Researchers at Wake Forest ... with other institutions, report in Experimental Hematology ...
... firefighters for the range of scenarios they are ... Michael R. Baumann, Carol L. Gohm, and Bryan ... Factors article, "Phased Training for High-Reliability Occupations: ... the value of current scenario-based training programs. ...
... Nov. 2 (HealthDay News) -- A rare occurrence of people ... same time has been confirmed by researchers. The co-infection ... strain called H3N2 was identified in a young Cambodian boy ... the genomes of both viruses showed that the viruses did ...
... Epstein-Barr virus (EBV) infects nine out of ten people ... early childhood often cause no disease symptoms, but people ... mononucleosis, a disease characterized by swollen lymph nodes, fever ... kinds of cancer, including Hodgkin lymphoma and stomach and ...
Cached Medicine News:Health News:FDA OKs Heart Valve That Does Not Require Open-Heart Surgery 2Health News:FDA OKs Heart Valve That Does Not Require Open-Heart Surgery 3Health News:Brain probe that softens after insertion causes less scarring 2Health News:Brain probe that softens after insertion causes less scarring 3Health News:Gene therapy shows promise as hemophilia treatment in animal studies 2Health News:Current training programs may not prepare firefighters to combat stress 2Health News:It's Possible to Come Down With Two Flu Viruses at Once 2Health News:NIH scientists outline steps toward Epstein-Barr virus vaccine 2
Liquichek Autoimmune Controls are individual controls for monitoring the performance of autoimmune assays....
Lyphochek Benzo/TCA Control Set A is ideal for monitoring HPLC methods for identification and quantitation of benzodiazepines and tricyclic antidepressant drugs....
Lyphochek Therapeutic Drug Monitoring Control (TDM) contains over 40 analytes with assayed values at three clinically significant levels....
Lyphochek Urine Metals Control incorporates two levels of critical trace elements, heavy metals and organic metabolites, and is ideal for environmental and industrial testing....
Medicine Products: